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Abstract
Background: Thirty-two common variants associated with body mass index (BMI) have been identified in genome-wide
association studies, explaining ,1.45% of BMI variation in general population cohorts. We performed a genome-wide
association study in a sample of young adults enriched for extremely overweight individuals. We aimed to identify new loci
associated with BMI and to ascertain whether using an extreme sampling design would identify the variants known to be
associated with BMI in general populations.
Methodology/Principal Findings: From two large Danish cohorts we selected all extremely overweight young men and
women (n=2,633), and equal numbers of population-based controls (n=2,740, drawn randomly from the same populations
as the extremes, representing ,212,000 individuals). We followed up novel (at the time of the study) association signals
(p,0.001) from the discovery cohort in a genome-wide study of 5,846 Europeans, before attempting to replicate the most
strongly associated 28 SNPs in an independent sample of Danish individuals (n=20,917) and a population-based cohort of
15-year-old British adolescents (n=2,418). Our discovery analysis identified SNPs at three loci known to be associated with
BMI with genome-wide confidence (P,5610
28; FTO, MC4R and FAIM2). We also found strong evidence of association at the
known TMEM18, GNPDA2, SEC16B, TFAP2B, SH2B1 and KCTD15 loci (p,0.001), and nominal association (p,0.05) at a further
8 loci known to be associated with BMI. However, meta-analyses of our discovery and replication cohorts identified no novel
associations.
Significance: Our results indicate that the detectable genetic variation associated with extreme overweight is very similar to
that previously found for general BMI. This suggests that population-based study designs with enriched sampling of
individuals with the extreme phenotype may be an efficient method for identifying common variants that influence
quantitative traits and a valid alternative to genotyping all individuals in large population-based studies, which may require
tens of thousands of subjects to achieve similar power.
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Introduction
Genome-wide association (GWA) studies have successfully
identified genetic loci associated with body mass index (BMI)
[1–3]. Despite the very large sample-sizes employed in these
studies (.120,000 in the most recent), most of the heritability has
yet to be explained, with the 32 confirmed loci accounting for only
,1.45% of the variance in BMI (2–4% of the genetic variance)
[3].
Given the difficulty in identifying loci responsible for small
proportions of the phenotypic variance in BMI, a number of
strategies have been proposed to increase the power to detect
association. One suggestion has been to selectively genotype
individuals at either one or both ends of the distribution of BMI
scores (i.e. obese and/or extremely lean individuals) [4–7]. The
rationale is that individuals taken from the extreme ends of the
sample are more likely to be enriched for alleles of interest than
individuals sampled from the middle of the distribution.
Theoretically, under simple models of many variants of small
effect, this selection strategy should markedly increase power to
detect association relative to a similar size sample of unselected
individuals. Case individuals can be considered, under certain
assumptions, to reflect extreme scores on an underlying continuous
distribution of disease liability, which is the primary reason why
case-control studies are expected to have greater power to detect
loci than the same number of individuals selected randomly from a
population cohort.
Less well appreciated is that under certain scenarios, selecting
extreme individuals will not always increase power to detect
common genetic variants [8]. One reason is that some individuals
exhibiting extreme trait values may carry rare alleles of large
effect, rather than reflecting the normal variation from common
alleles at quantitative trait loci. Consequently, an extreme sample
may not be enriched for common alleles of interest. Whilst rare
alleles will also be of interest, it may be difficult to identify them via
genome-wide association, since commercial SNP chips have
limited ability to tag rare variants [9] and the power to detect
rare variants via genetic association is low in general. In addition,
individuals may exhibit extreme BMI because of non-genetic
factors or rare combinations of gene-gene or gene-environment
interactions, all of which may also decrease power to detect
common variants of small effect. Thus if the extremes have risk
factors that are unique from the general distribution of BMI, such
a study design may not be useful for identifying general population
BMI risk alleles.
Three previous GWA studies have employed an extreme
sampling strategy to detect obesity loci. One study, which
compared gastric bypass surgery patients with population controls,
found no novel loci, but reported that 6 of the 12 BMI variants
known at the time were associated with risk of severe obesity,
suggesting that generally obesity represents the extreme of a
phenotypic spectrum, rather than a distinct condition [10].
Another study, sampled early-onset obese children and morbidly
obese (BMI.40 kg/m
2) adults, and compared them to normal
weight controls [11]. As well as identifying variants in FTO and
MC4R, they detected a further three loci associated with obesity
(NPC1, MAF and PTER). Another, aimed to identify variants
associated with early-onset extreme obesity [12]. They detected
the known FTO, MC4R and TMEM18 loci as well as two novel
loci (SDCCAG8 and TNKS/MSRA). However, the authors of these
three studies analysed the data using a dichotomous coding (i.e.
obese vs non-obese), effectively discarding information from the
underlying continuous distribution of BMI values. Since case-
control methods ignore the underlying BMI trait values, they do
not make complete use of the data, and are therefore inefficient
and likely to be less powerful than approaches that incorporate
quantitative information [13].
In this study we aimed to investigate the genetic profile at the
upper extreme of the BMI distribution using a population sample
enriched for these individuals. We employed a genome-wide
association approach including a large sample of 2,633 extremely
overweight young Danish adults from the top 1% (males) and 4%
(females) of the distribution of BMI scores, and an approximately
equal number of control individuals (randomly selected from the
same populations that the extremely overweight individuals were
identified in), whilst retaining the quantitative BMI information of
these individuals in the analysis. Our aims were twofold: (i) to
detect new variants associated with obesity and more generally,
BMI; and (ii) to ascertain whether an extreme sampling design
could be used to powerfully detect BMI variants previously
identified using population based samples.
Methods
Figure 1 depicts the flow of analysis and SNP selection through
discovery and replication stages carried out in this study.
GOYA discovery analysis
GOYA participants. We employed a case-cohort sampling
design in which cases were defined as the individuals in a cohort
with the upper-most extreme BMI scores and the controls selected
by random sampling from the same cohort. Two different cohorts
were used, the Danish National Birth Cohort for women and a
draft board examination cohort for men, both of which were
constituted by young Danish adults with negligible admixture of
other ethnicities.
In total, 91,387 pregnant women were recruited to the Danish
National Birth Cohort during 1996–2002. The study is described
in detail elsewhere [14], but pertinent to this study, pre-pregnancy
BMI was calculated from self-reported height and weight collected
during a telephone interview at ,16 weeks of gestation. We
included in the current study the 67,853 women who had given
birth to a live born infant, had provided a blood sample during
pregnancy and had BMI information available [14]. We selected
the 3.6% of these women with the largest residuals from the
regression of BMI on age and parity (all entered as continuous
variables). The BMI for these 2451 women ranged from 32.6 to
64.4. From the remaining cohort we selected a random sample of
similar size (2450). Of these, 1,960 extremely overweight and
1,948 control women were genotyped (and passed quality control
(QC), 102 failed QC). With a sampling fraction of 3.6%, these
controls represent about 54,000 women.
A randomly selected control group of one in every hundred men
(n=3,601) and all extremely overweight men (n=1,930) were
identified from the records of 362,200 Caucasian men examined
at the mean age of 20 years at the draft boards in Copenhagen and
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and weight (in underwear only) were measured at the draft board
examinations. Obesity was defined as 35% overweight relative to a
local standard in use at the time (mid 1970’s), corresponding to a
BMI $31.0 kg/m
2, which proved to be above the 99th percentile.
All extremely overweight men and a random sample of half the
men, who were still living in the region, were invited to a follow-up
survey in 1992–94 at the mean age of 46 years, at which time the
blood samples were taken (753 extremely overweight and 879
control men attended). The criteria for invitation to the follow-up
surveys and participation have been described previously [15,16].
Of these, 673 extremely overweight and 792 control men were
genotyped (and passed quality control (QC), 61 failed QC). With a
sampling fraction of 0.5% (50% of 1%), these controls represent
about 158,000 men among whom the case group was the most
obese.
The study was approved by the regional scientific ethics
committee and by the Danish Data Protection Board.
Genotyping. Genome-wide genotyping on the Illumina
610 k quad chip was carried out at the Centre National de
Ge ´notypage (CNG), Evry, France. We excluded SNPs with minor
allele frequency ,1%, .5% missing genotypes or which failed an
exact test of Hardy-Weinberg equilibrium (HWE) in the controls
(p,10
27). We also excluded any individual who did not cluster
with the CEU individuals (Utah residents with ancestry from
northern and western Europe) in a multidimensional scaling
analysis seeded with individuals from the International HapMap
release 22 (22 individuals) (Figure S1 - there was little evidence
for additional population stratification as shown by the
GWAS lambdas: 1.05 and 1.06), who had .5% missing data
(5 individuals), outlying heterozygosity of .35% or ,30.2%
(35 individuals), both samples in the case of genetic duplicates
(4 individuals), one of each pair of genetically related individuals
(50 individuals), 4 individuals with sex discrepancies and one
individual whose genotyping was discordant with a previous
project. After data cleaning, 5,373 individuals (2,633 extremely
overweight and 2,740 random controls) and 545,349 SNPs
remained. We carried out imputation to HapMap release 22
(CEU individuals) using Mach 1.0, Markov Chain Haplotyping
[17].
Genome-wide association analysis. We analysed only
those imputed SNPs, which had a minor allele frequency .0.01
and an R
2 imputation quality score .0.3. We carried out genome-
wide association analysis using two analysis methods.
We first regressed overweight/control status on expected
genotype dosage (adjusting for age and sex) using the software
package MACH2DAT, which accounts for uncertainty in
prediction of the imputed data by weighting genotypes by their
posterior probabilities [17]. However, it is possible that this
method does not make optimal use of the data in that it ignores
quantitative information within the extreme and central parts of
the BMI distribution.
We therefore also analysed BMI as a quantitative trait using
linear regression of sex-specific BMI z-scores on genotype,
including age as a covariate (in STATA). Z-scores were
constructed using the mean and standard deviation of the
randomly selected normal weight control group. Though the p-
value from such an analysis is not biased, the estimated regression
coefficient for BMI on genotype is biased because of the non-
normality of BMI with the case-cohort sampling design and we
therefore only report the p-value and direction of effect (sign of
beta coefficient) for this analysis. Genomic inflation was measured
by l=median(chi
2)/0.456.
Stage 1 replication
We selected SNPs for in silico replication if they had a p,0.001
in either the overweight/control or BMI z-score linear regression
GWAS, but excluded SNPs from any region where there was a
previously confirmed association with BMI or obesity at the time
of the study (i.e. FTO, FAIM2, MC4R, SEC16B, GNPDA2,
KCTD15, TMEM18, SH2B1, NEGR1, ETV5, BDNF, MTCH2
regions, Figure 2) [1,2,11].
Stage 1 replication was conducted using data available from the
International Agency for Research on Cancer (IARC). Full details
of the participants, genotyping and analysis are in Text S1. The
data were analysed using linear regression of the inverse rank
normal BMI, adjusted for age, sex and country.
GeneSniffer. We used GeneSniffer (www.genesniffer.org) to
prioritize genes within the LD vicinity (+/20.1 cM) of each of the
discovery associated SNPs (p,5610
25) for trait candidacy by
assigning a relevance score (full details available in Text S1).
Stage 2 replication
Following the in silico replication we took the best SNPs
forward to replication genotyping in several Danish cohorts and in
silico replication in the ALSPAC cohort.
SNPs for the final stage of replication were selected according to
three strategies. First, the top SNP from each region which showed
moderate evidence of association (i.e. p,0.001) from the z-score
linear regression analysis of BMI in the discovery cohort and also
displayed nominal evidence of replication in the IARC cohort (i.e.
p,0.01 in the same direction) were selected for further replication.
Secondly, the top SNP was taken from any region with p,1610
25
in either of the two discovery cohort analyses and with the same
direction of effect in the IARC replication sample. Lastly, the top
SNP from any region with p,5610
25 in either of the two
Figure 1. Discovery and replication process. GOYA=Genetics of
Overweight Young Adults. IARC=International Agency for Research on
Cancer. ALSPAC=Avon Longitudinal Study of Parents and Children.
doi:10.1371/journal.pone.0024303.g001
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IARC replication sample and with evidence of candidacy (as
assessed by GeneSniffer or from other published evidence).
Stage 2 replication was carried out in a set of Danish cohorts
and the Avon Longitudinal Study of Parents and Children
(ALSPAC). Full details on the participants, genotyping and
analysis are in Text S1 and Table S1. The data were analysed
by linear regression of sex-specific BMI z-score on genotype,
adjusting for age and EIGENSTRAT values, as appropriate.
Meta-analysis
To estimate an overall p-value for each of the SNPs, we
p e r f o r m e da nu n w e i g h t e dS t o u f f e r’s Z-transform meta-analysis
(inputting the p-value and direction of effect from each study to
construct a directional z-score and applying equal weights to
each study to generate an overall Z-score and p-value) on all
participating cohorts in METAL (http://www.sph.umich.edu/
csg/abecasis/Metal/) using the analysis from each cohort
which analysed z-score BMI as a continuous trait (we re-
a n a l y s e dt h eI A R Cd a t au s i n gt h es a m em e t h o d sa st h eo t h e r
cohorts - linear regression of BMI z-score on genotype,
adjusting for age).
Results
Discovery cohorts
Whilst the GOYA men were selected from a much larger cohort
and the overweight group was more extreme, the GOYA women
had higher average BMI (1.2 kg/m
2 higher in the controls and
3.8 kg/m
2 higher in the overweight group) (Table 1), which can
be attributed to the fact that they were sampled later in the
development of the obesity epidemic and that they were older than
the men. However, the pattern of association looked similar across
the two genders, so the two groups were analysed together
assuming that the genotype-phenotype associations across the
entire phenotype distribution of the two populations were the same
(data not shown).
The QQ plots for the genome-wide analyses in the discovery
cohort for the two analysis methods were broadly similar and
demonstrated little evidence of systematic inflation from expecta-
tion. Lambda values for BMI z-score linear regression and
overweight/control analyses were consistent with this observation:
l=1.06 and l=1.05 respectively). Despite this, there was
evidence for favourable departure of test metrics from the null
expectation towards the extremes (Figure 3 & Figure S2).
Specifically, three regions showed p-values with considerable
genome-wide evidence against the null hypothesis (defined as
p,5610
28)( Table 2). These three regions (FTO, FAIM2 and
MC4R) have previously been associated with BMI and other
related traits [1,2] (Figure 2). The next two most strongly
associated regions (p,1610
25) in our analyses (SEC16B and
GNPDA2) have also been associated with BMI previously [1,2]. In
total 22 regions had p,1610
25 in the overweight/control or the
BMI z-score linear regression analysis (Table 2, Figure 4,
Figure S3).
Nine of the 32 variants associated with BMI in the recent
GIANT GWA study [3] had p,0.001 (and an effect in the same
direction) in our in BMI z-score linear regression analysis
Table 1. Summary characteristics of the GOYA study
participants.
Men Women
Overweight
N=673
Normal
N=792
Overweight
N=1960
Normal
N=1948
Age, years 19 (18–24) 19 (18–24) 29 (22–36) 29 (22–36)
Height, cm 177 (167–188) 177 (166–188) 168 (158–178) 169 (160–180)
Weight, kg 104 (91–124) 67 (55–83) 103 (89–128) 64 (51–86)
BMI, kg/m
2 32.5 (31.6–34.1) 21.3 (18.4–24.7) 36.3 (33.8–43.9) 22.5 (18.6–30.1)
Values are median (5–95 percentile range).
doi:10.1371/journal.pone.0024303.t001
Figure 2. The overlap of previously known BMI hits, GIANT BMI
hits and GOYA results. Shown are the loci with p,0.0001 in the
current GOYA study (that were taken through to replication), the
previously known BMI hits [1,2,11] and the recent GIANT BMI hits [3].
The light grey shaded area shows the loci which had p,0.001 in GOYA,
but were excluded from replication because there was already strong
evidence for an association with BMI and the dark grey shaded area
shows the TFAP2B loci which we included in our replication stage (as it
had not been identified in previous studies) and found genome-wide
significant evidence for its association with BMI, and since our
replication stage it has been identified as associated with BMI in the
GIANT study. The grey previously associated loci had p,0.05 in GOYA.
*p,561028 in GOYA discovery analysis, ** p,0.001 in GOYA discovery
& replication meta-analysis.
doi:10.1371/journal.pone.0024303.g002
Figure 3. QQ plot for the GOYA BMI z-score linear regression
genome-wide analysis. Lambda=1.057.
doi:10.1371/journal.pone.0024303.g003
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p,0.05 (and an effect in the same direction) (Table 3). In
contrast, 15 of the GIANT BMI-associated genes failed to show
evidence of association (i.e. p.0.05) in our discovery cohort,
although all but one showed an effect in the same direction. We
found p,0.05 (and an effect in the same direction) for one of the
three loci (PTER) identified in the Meyre et al. extremes scan [11].
There was no evidence in our study for association with the other
two loci (MAF and NPC1) from the Meyre et al. paper or with the
two loci (SDCCAG8 and TNKS/MSRA) from the Scherag et al
paper [12] (p.0.05 and effects in the opposite direction to the
original studies). The majority of known SNPs had lower p-values
in the BMI z-score linear regression analysis than the analysis of
overweight versus normal individuals, although in most cases the
difference was relatively small (i.e. less than an order of magnitude)
(Table 3).
In total, 3,741 SNPs had p,0.001 in the overweight/control
analysis and 4,297 SNPs had p,0.001 in the BMI z-score
linear regression analysis, resulting in 6,045 SNPs with a
p,0.001 in at least one of these analyses (Table S2 contains a
full list of these SNPs), which is more than one would expect by
chance (2,544 each for independent traits and SNPs). 487 SNPs
were in regions that have been previously associated with BMI
or obesity (Figure 2) [2,1,11]. We therefore selected the
remaining 5,558 SNPs for in silico replication in the IARC
sample.
Table 2. Top SNP per region for all GOYA hits p,1610
25 in either the overweight/control dichotomous analysis or the
quantitative BMI linear regression ananlysis.
Overweight/control
analysis
BMI linear
regression analysis
chr position MARKER
EFFECT
ALLELE
OTHER
ALLELE
EFFECT ALLELE
FREQ R
2 OR 95% CI p beta
1 p
known
genes
16 52376670 rs9936385 C T 0.42 0.94 1.35 1.25,1.46 1.4E-13* + 2.8E-1*
/** FTO
12 48549415 rs7132908 A G 0.44 0.98 1.26 1.17,1.37 6.1E-09* + 1.8E-08*
/** FAIM2
18 56009809 rs8089364 C T 0.30 0.99 1.23 1.14,1.34 7.20E-07 + 3.2E-08*
/** MC4R
1 176144602 rs604388 C T 0.36 1 1.21 1.12,1.31 2.20E-06 + 5.80E-07* SEC16B
4 44870448 rs13130484 C T 0.58 1 0.85 0.78,0.91 1.90E-05 2 1.60E-06* GNPDA2
3 191585563 rs17504169 A G 0.15 0.99 1.23 1.11,1.37 1.40E-04 + 2.80E-06
6 33183421 rs910320 C T 0.77 0.98 0.84 0.77,0.92 2.30E-04 2 3.20E-06
18 10426288 rs2115706 A G 0.63 0.81 1.20 1.1,1.31 5.50E-05 + 6.00E-06
5 164598808 rs7720663 A G 0.60 1 1.16 1.07,1.25 2.30E-04 + 6.30E-06
12 130882177 rs4964926 C G 0.91 0.85 0.73 0.63,0.85 4.00E-05 2 6.60E-06
5 138008375 rs3849047 C T 0.67 0.88 1.18 1.08,1.29 1.30E-04 + 6.90E-06
6 50944238 rs734597 A G 0.17 0.98 1.25 1.13,1.39 2.00E-05 + 7.00E-06
17 41439785 rs8067056 C T 0.36 0.95 1.19 1.09,1.29 4.30E-05 + 8.30E-06
16 51179613 rs11640537 A G 0.19 1 1.20 1.09,1.33 1.70E-04 + 9.90E-06
5 145822662 rs17104665 A G 0.93 1 1.41 1.22,1.64 4.50E-06 + 1.20E-05
9 114439415 rs2798311 C T 0.95 0.64 1.71 1.36,2.14 3.80E-06 + 1.80E-05
11 38745191 rs11034952 C T 0.57 1 1.19 1.11,1.29 5.60E-06 + 3.10E-05
14 21857530 rs10047878 A T 0.54 0.99 0.83 0.77,0.90 2.60E-06 2 4.80E-05
9 128502322 rs10987417 G T 0.61 0.92 0.83 0.76,0.90 5.10E-06 2 5.10E-05
14 31842078 rs6571507 A G 0.37 0.99 1.20 1.11,1.29 7.70E-06 + 7.70E-05
2 17902293 rs6758546 A G 0.10 1 0.75 0.66,0.85 9.20E-06 2 8.80E-05
2 23392348 rs1002158 G T 0.73 1 0.82 0.75,0.89 6.80E-06 2 1.20E-04
*regions with previous evidence for association with obesity.
**genome-wide significant p,5610
28.
1only the sign (+/2) of the beta coefficients are shown for the BMI linear regression analysis, as the extreme sampling strategy will produce biased beta coefficients.
R
2 is the MACH derived imputation quality score. OR denotes odds ratio, CI denotes confidence interval, ‘beta’ for the BMI linear regression analysis denotes the sign of
the coefficient.
doi:10.1371/journal.pone.0024303.t002
Figure 4. Manhattan Plot for the GOYA BMI z-score linear
regression genome-wide analysis.
doi:10.1371/journal.pone.0024303.g004
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We obtained results data for the association of 5,552 SNPs and
inverse rank normal BMI from the IARC study (n=5,846). Forty-
four of these 5,552 SNPs had p,0.01 and an effect in the same
direction as that observed in the GOYA sample (full results
available in Table S2). These 44 SNPs are in 10 loci. 18
additional SNPs met the other criteria for stage two replication (if
they didn’t meet p,0.01 in IARC we still included SNPs with the
Table 3. GOYA result for previously identified BMI loci.
GIANT GOYA
Gene Chr SNP position effect other
freq
effect p
per allele
change
in BMI SE BMI p beta obesity p OR 95% CI
FTO 16 rs1558902 52,361,075 a t 0.42 4.80E-120 0.39 0.02 3.90E-15* + 4.90E-14* 1.34 1.24,1.45
TMEM18 2 rs2867125 612,827 c t 0.83 2.80E-49 0.31 0.03 2.20E-04* + 4.20E-04* 1.21 1.09,1.34
MC4R 18 rs571312 55,990,749 a c 0.24 6.40E-42 0.23 0.03 4.90E-07* + 4.60E-06* 1.22 1.12,1.33
GNPDA2 4 rs10938397 44,877,284 g a 0.43 3.80E-31 0.18 0.02 2.00E-06* + 2.20E-05* 1.18 1.10,1.28
BDNF 11 rs10767664 27,682,562 a t 0.78 4.70E-26 0.19 0.03 0.018* + 0.139 1.07 0.98,1.18
SEC16B 1 rs543874 176,156,103 g a 0.19 3.60E-23 0.22 0.03 2.20E-05* + 6.50E-05* 1.20 1.10,1.32
NEGR1 1 rs2815752 72,585,028 a g 0.61 1.60E-22 0.13 0.02 0.01* + 0.04* 1.08 1.00,1.17
RBJ 2 rs713586 25,011,512 c t 0.47 6.20E-22 0.14 0.02 0.058 + 0.033* 1.09 1.01,1.17
GPRC5B 16 rs12444979 19,841,101 c t 0.87 2.90E-21 0.17 0.03 0.421 + 0.941 1.00 0.89,1.13
SH2B1 16 rs7359397 28,793,160 t c 0.4 1.90E-20 0.15 0.02 4.50E-04* + 0.001* 1.14 1.05,1.23
TFAP2B 6 rs987237 50,911,009 g a 0.18 2.90E-20 0.13 0.03 1.00E-05* + 2.70E-05* 1.24 1.12,1.37
MAP2K5 15 rs2241423 65,873,892 g a 0.78 1.20E-18 0.13 0.02 0.226 + 0.288 1.05 0.96,1.15
ETV5 3 rs9816226 187,317,193 t a 0.82 1.70E-18 0.14 0.03 0.159 + 0.249 1.06 0.96,1.18
FAIM2 12 rs7138803 48,533,735 a g 0.38 1.80E-17 0.12 0.02 4.60E-07* + 6.40E-08* 1.24 1.15,1.34
QPCTL 19 rs2287019 50,894,012 c t 0.8 1.90E-16 0.15 0.03 0.045* + 0.133 1.07 0.98,1.18
TNNI3K 1 rs1514175 74,764,232 a g 0.43 8.20E-14 0.07 0.02 0.001* + 0.001* 1.14 1.05,1.23
SLC39A8 4 rs13107325 103,407,732 t c 0.07 1.50E-13 0.19 0.04 0.035* + 0.058 1.19 0.99,1.43
FLJ35779 5 rs2112347 75,050,998 t g 0.63 2.20E-13 0.1 0.02 0.365 + 0.526 1.03 0.95,1.11
LRRN6C 9 rs10968576 28,404,339 g a 0.31 2.70E-13 0.11 0.02 0.106 + 0.366 1.04 0.96,1.12
MTCH2 11 rs3817334 47,607,569 t c 0.41 1.60E-12 0.06 0.02 0.037* + 0.039* 1.08 1.00,1.17
TMEM160 19 rs3810291 52,260,843 a g 0.67 1.60E-12 0.09 0.02 0.345 + 0.232 1.06 0.97,1.16
FANCL 2 rs887912 59,156,381 t c 0.29 1.80E-12 0.1 0.02 0.563 + 0.642 0.98 0.90,1.07
NRXN3 14 rs10150332 79,006,717 c t 0.21 2.80E-11 0.13 0.03 0.556 + 0.517 1.03 0.94,1.13
CADM2 3 rs13078807 85,966,840 g a 0.2 3.90E-11 0.1 0.02 0.016* + 0.017* 1.12 1.02,1.23
PRKD1 14 rs11847697 29,584,863 t c 0.04 5.80E-11 0.17 0.05 0.011* + 0.03* 1.24 1.02,1.51
LRP1B 2 rs2890652 142,676,401 c t 0.18 1.40E-10 0.09 0.03 0.655 + 0.938 1.00 0.91,1.09
PTBP2 1 rs1555543 96,717,385 c a 0.59 3.70E-10 0.06 0.02 0.756 + 0.773 1.01 0.94,1.09
MTIF3 13 rs4771122 26,918,180 g a 0.24 9.50E-10 0.09 0.03 0.072 + 0.111 1.08 0.98,1.18
ZNF608 5 rs4836133 124,360,002 a c 0.48 2.00E-09 0.07 0.02 0.845 2 0.394 0.97 0.89,1.05
RPL27A 11 rs4929949 8,561,169 c t 0.52 2.80E-09 0.06 0.02 0.111 + 0.389 1.03 0.96,1.12
KCTD15 19 rs29941 39,001,372 g a 0.67 3.00E-09 0.06 0.02 3.00E-04* + 6.30E-05* 1.18 1.09,1.28
NUDT3 6 rs206936 34,410,847 g a 0.21 3.00E-08 0.06 0.02 0.981 + 0.821 1.01 0.92,1.11
Meyre et al. 2009**
PTER 10 rs10508503 16,339,957 c t NA 2.10E-07 NA NA 0.029* + 0.098 1.12 0.98,1.29
MAF 16 rs1424233 78,240,252 a g NA 3.80E-13 NA NA 0.655 2 0.399 0.97 0.90,1.04
NPC1 18 rs1805081 19,394,430 g a NA 2.90E-07 NA NA 0.634 2 0.640 0.98 0.91,1.06
Scherag et al. 2010**
SDCCAG8 1 rs12145833 241,550,377 t g NA 4.80E-07 NA NA 0.962 2 0.957 1.00 0.90,1.10
TNKS/MSRA 8 rs17150703 9,783,208 a g NA 1.90E-09 NA NA 0.813 2 0.366 0.94 0.83,1.07
*p,0.05 in GOYA. BMI refers to the ‘BMI p’ linear regression analysis and ‘obesity p’ refers to overweight/control analysis. ‘beta’ for the BMI linear regression denotes the
sign of the coefficient, with ‘+’ indicating the same direction of effect as in GIANT [3].
**overall effect estimates not available for Meyre et al. 2009 [11] or Scherag et al. 2010 [12]. Effect allele is the BMI increasing allele (according to the stage 2 adult results
in Meyre et al. 2009). NA=not available.
doi:10.1371/journal.pone.0024303.t003
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GOYA (p,1610
25), in addition to including those with moderate
evidence of association in GOYA (p,5610
25) and evidence of
candidacy), providing a total of 28 SNPs for replication (rationale
for inclusion of each SNP in the replication are shown in
Supplementary Table S3).
Stage 2 replication
Of the 28 SNPs only one (rs734597) had p,0.05 and an effect
in the same direction in the ALSPAC cohort and three
(rs734597, rs6758546 and rs12130212) had p,0.01 and an
effect in the same direction in the Danish replication cohort
(Table 4). We carried out a meta-analysis of all cohorts and
rs734597 was the only SNP to reach genome-wide significance
(p=3.1610
28), with the ‘‘A’’ allele associated with increased
BMI. This SNP is in the TFAP2B gene, which has also recently
been identified by GIANT as being associated with BMI
(Figure 2, Table 3) [3]. Of the other 27, although none
reached genome-wide significance, 13 showed consistent direc-
tions of effect across all cohorts (where only 6 or 7 would be
expected by chance) and 6 SNPs (in/near CAMK1G, RGS6,
FLJ39743, TLE3, CENTD3 and AKAP6) had smaller p-values in
the meta-analysis than in the discovery.
Discussion
In this study we found strong evidence of association between
BMI and many known BMI loci, including FTO, MC4R,
TMEM18, GNPDA2, FAIM2, SEC16B, TFAP2B, SH2B1 and
KCTD15 using an efficient and powerful selective genotyping
approach. Although we did not identify any new BMI loci that
reached genome-wide confidence levels in the combined meta-
analysis, a number of variants showed consistent directions of
effect in the replication analyses (more than expected by chance)
and it would be worth following up these loci in other cohorts to
investigate a possible small effect on BMI.
There has been some concern that study designs which involve
genotyping individuals with extreme phenotypic scores from one
or both ends of the distribution may not translate into increased
power to detect common variants in genome-wide association
analysis if the individuals at the extremes are not enriched for
common alleles, but instead harbor rare alleles of large effect
and/or are influenced by extreme environmental factors. We
have shown that it was possible to replicate many of the known
common variants underlying variance in BMI using a sample
selected for extreme obesity compared to a sample of randomly
selected controls from the same population, demonstrating that
the extremes may be enriched for the common variants.
Additionally, many of the variants identified showed strong
evidence of association in our sample using much smaller
numbers than previous genome-wide association studies, most of
which involved tens of thousands of individuals combined via
meta-analysis. For example, our discovery strategy successfully
identified the FAIM2 region at genome-wide significant levels
using far fewer numbers (n=5,373) than the initial study, which
identified this region as associated with BMI (n=34,416) [1].
Many of the other known BMI-associated regions were also near
the top of our p-value distribution, and had this been an initial
discovery study, we would have identified several of the known
hits using the present efficient study design. Consistent with
Cotsapas et al. [10] (who compared severely obese individuals
with controls) we found little/no evidence for association
between BMI and ETV5, NPC1 or MAF variants using our
extreme genotyping design. However, for the 10 other known
BMI SNPs studied both in the Cotsapas et al paper and here, we
found stronger evidence for all, including four (MC4R, MTCH2,
SEC16B and BDNF), for which we found evidence for
association, whilst Cotsapas et al. report little or none.
Seventeen of the known BMI loci showed little evidence for
association using our extreme study design. However, most of
these were only recently found to be associated in the
exceptionally large GIANT study [3] and have very small effect
sizes, which even with our efficient design, we had little power to
detect. Of interest are the variants in/near five genes (PTER,
NPC1, MAF, SDCCAG8 and TNKS/MSRA)t h a th a dp r e v i o u s l y
been associated with obesity also using samples of individuals
who were extremely overweight [11,12]. GIANT found limited
or no evidence of association at these variants with BMI [3]. We
found evidence for an association with the PTER variant in
o u re x t r e m e sl i n e a rr e g r e s s i o nanalysis, but no evidence of
association with the other four variants. It could be that the
PTER variant specifically conveys risk of extreme obesity, and is
not associated with the general distribution of BMI e.g. tagging
rare SNPs of large effect. The reason for lack of association with
the other two genes in our study could be that they are
associated only with extreme obesity in a particularp o p u l a t i o n
(i.e. children and adolescents for TNKS/MSRA), perhaps
dependent on particular gene-environment interactions or that
we did not have the power to detect them in our discovery
sample.
One SNP which we took forward to replication reached
genome-wide significance in the combined meta-analysis
(rs734597 in TFAP2B). Variants within this gene have been
previously associated with waist circumference and waist hip ratio
[18] so it was perhaps not surprising that this locus was associated
with BMI/obesity too, and since our discovery analysis a variant in
this gene (rs987237) in LD with rs734597 (r
2=1) was shown to be
associated with BMI [3]. We did not identify any novel variants
associated with BMI at genome-wide confidence levels. This might
be because although we used a powerful study design in our
discovery set, drawn from a population of ,212,000 individuals,
we attempted replication in population samples, which have much
less power. As previous meta-analyses combining population
sample GWA studies have been much larger than our replication
sample, it would perhaps be unlikely to obtain genome-wide
significance in a population sample replication set of this size.
Finally we noticed that on the majority of occasions, analysing
the data using BMI z-score linear regression yielded stronger
evidence against the null for known obesity loci than treating BMI
as a dichotomous variable and analyzing the data via logistic
regression. Such a result is consistent with the literature, which
suggests that the inclusion of quantitative information usually
yields a more powerful test of association [13,15,16].
In summary, we have confirmed that employing a selective
genotyping design whereby extremely overweight individuals are
compared to individuals from a random population sample is a
powerful way to identify common variants of relatively small effect
that influence BMI. Many of the variants that were previously
found to influence BMI in large population based cohorts also
showed strong or nominal levels of association in our study. Our
results suggest that population-based study designs with enriched
sampling of individuals with the extreme phenotype, combined
with using the phenotype as a quantitative trait may be an efficient
and powerful method for identifying common variants that
influence BMI and possibly other quantitative traits and a valid
alternative to genotyping all individuals in large population-based
studies, which may require tens of thousands of subjects to achieve
similar levels of power.
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Figure S1 MDS Plot for the GOYA participants. Seeded with
the HapMap CEU (Utah residents with northern and western
European ancestry from the CEPH collection), YRI (Yoruba from
Ibadan, Nigeria) and JPT and CHB (Japanese from Tokyo, Japan and
Chinese from Beijing, China) panels (release 22). Blue curves indicate
the thresholds outside of which GOYA individuals were excluded
from the GWAS. There was little evidence for additional population
structure as indicated by the GWAS lambdas l=1.05 and 1.06.
(TIF)
Figure S2 QQ plot for the GOYA overweight/control
genome-wide analysis. Lambda=1.051.
(TIF)
Figure S3 Manhattan plot for the GOYA overweight/
control genome-wide analysis.
(TIF)
Table S1 Characteristics of the six Danish stage 2 replication
cohorts.
(PDF)
Table S2 GOYA and IARC results for the 6,045 SNPs with
p,0.001 in GOYA. Known SNPs were excluded from the IARC
analysis.
(PDF)
Table S3 Reasons for including each SNP in the stage 2
replication.
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Text S1 Stage 1 Replication—IARC participants, genotyping
and analysis; GeneSniffer methods; Stage 2 Replication—Danish
Cohorts participants, genotyping and analysis; and Stage 2
Replication—ALSPAC participants, genotyping and analysis.
(DOC)
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